Definition of pulmonary embolism‐related death and classification of the cause of death in venous thromboembolism studies: Communication from the SSC of the ISTH-Reference-Cited by-同舟云学术

Definition of pulmonary embolism‐related death and classification of the cause of death in venous thromboembolism studies: Communication from the SSC of the ISTH

Published:2020-06 Issue:6 Volume:18 Page:1495-1500
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Tritschler Tobias¹²^ORCID,Kraaijpoel Noémie³,Girard Philippe⁴⁵,Büller Harry R.³,Langlois Nicole¹,Righini Marc⁶,Schulman Sam⁷⁸,Segers Annelise⁹,Le Gal Grégoire¹^ORCID,

Affiliation:

1. Department of Medicine Ottawa Hospital Research Institute University of Ottawa Ottawa ON Canada

2. Department of General Internal Medicine, Inselspital Bern University Hospital University of Bern Bern Switzerland

3. Department of Vascular Medicine Amsterdam UMC University of Amsterdam Amsterdam the Netherlands

4. Institut du Thorax Curie‐Montsouris Paris France

5. Institut Mutualiste Montsouris Paris France

6. Division of Angiology and Hemostasis Faculty of Medicine Geneva University Hospital Geneva Switzerland

7. Department of Medicine McMaster University Hamilton ON Canada

8. Department of Obstetrics and Gynecology The First I.M. Sechenov Moscow State Medical University Moscow Russia

9. ITREAS Academic Research Organization Amsterdam the Netherlands

Funder

Canadian Institutes of Health Research

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.14769

Reference11 articles.

1. Definitions, adjudication, and reporting of pulmonary embolism–related death in clinical studies: A systematic review

2. Development of a standardized definition of pulmonary embolism‐related death: A cross‐sectional survey of international thrombosis experts

3. Diagnostic characteristics of lower limb venous compression ultrasonography in suspected pulmonary embolism: a meta-analysis

4. Complete venous ultrasound in outpatients with suspected pulmonary embolism

5. Committee for Medicinal Products for Human Use (CHMP). European Medicine Agency.Guideline on clinical investigation of medicinal products for the treatment of venous thromboembolic disease. EMA/CHMP/41230/2015. 2016.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of venous thromboembolism and adequacy of thromboprophylaxis in 2380 acutely-ill hospitalized patients: Results from the PROFMiG cohort study;Thrombosis Research;2024-11

2. Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models;Journal of Thrombosis and Haemostasis;2024-09

3. Incidence, risk factors for and prognostic role of thromboembolic events (TEEs) amongst patients with metastatic pancreatic adenocarcinoma (PAAD): a retrospective, single-center analysis;ecancermedicalscience;2024-08-14

4. Optimal initial duration of low molecular weight heparin lead-in before direct oral anticoagulants for short-term outcomes of hospitalized patients with non-high-risk acute pulmonary embolism;QJM: An International Journal of Medicine;2024-06-26

5. External validation of the Pulmonary Embolism-Syncope, Anemia, and Renal Dysfunction bleeding score for early major bleeding in patients with acute pulmonary embolism: from the COMMAND VTE Registry-2;Journal of Thrombosis and Haemostasis;2024-06